North America Contraceptives Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Condoms, Intrauterine Product (IUDs), Vaginal Rings, Implants, Patches, Diaphragms, Emergency Contraceptives, Sponges, and Others), End User (Home Care, Hospitals and Clinics), and Distribution Channel (Retail Pharmacy, Online Pharmacy, and Hospital Pharmacy)

No. of Pages: 122    |    Report Code: TIPRE00024757    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Contraceptives Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Contraceptives Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Contraceptives Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Awareness About Sexually Transmitted Diseases
  • 5.1.2 Strategic Initiative By Companies
5.2 Market Opportunities
  • 5.2.1 Government Initiatives and Collabrations in Developing Region
5.3 Future Trends
  • 5.3.1 Widespread Demand for Wearable Pregnancy Devices
5.4 Impact of Drivers and Restraints

6. North America Contraceptives Market Regional Analysis

6.1 North America Contraceptives Market Overview
6.2 North America Contraceptives Market Revenue 2019-2028 (US$ Million)
6.3 North America Contraceptives Market Forecast Analysis

7. North America Contraceptives Market Analysis – by Product

7.1 Condoms
  • 7.1.1 Overview
  • 7.1.2 Condoms: North America Contraceptives Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Intrauterine Product
  • 7.2.1 Overview
  • 7.2.2 Intrauterine Product: North America Contraceptives Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Vaginal Rings
  • 7.3.1 Overview
  • 7.3.2 Vaginal Rings: North America Contraceptives Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Implants
  • 7.4.1 Overview
  • 7.4.2 Implants: North America Contraceptives Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Patches
  • 7.5.1 Overview
  • 7.5.2 Patches: North America Contraceptives Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Diaphragms
  • 7.6.1 Overview
  • 7.6.2 Diaphragms: North America Contraceptives Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Emergency Contraceptives
  • 7.7.1 Overview
  • 7.7.2 Emergency Contraceptives: North America Contraceptives Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Sponges
  • 7.8.1 Overview
  • 7.8.2 Sponges: North America Contraceptives Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Contraceptives Market Analysis – by End User

8.1 Home Care
  • 8.1.1 Overview
  • 8.1.2 Home Care: North America Contraceptives Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Hospitals and Clinics
  • 8.2.1 Overview
  • 8.2.2 Hospitals and Clinics: North America Contraceptives Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Contraceptives Market Analysis – by Distribution Channel

9.1 Retail Pharmacy
  • 9.1.1 Overview
  • 9.1.2 Hospitals and Clinics: North America Contraceptives Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Online Pharmacy
  • 9.2.1 Overview
  • 9.2.2 Hospitals and Clinics: North America Contraceptives Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Hospital Pharmacy
  • 9.3.1 Overview
  • 9.3.2 Hospitals and Clinics: North America Contraceptives Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Contraceptives Market – North America Analysis

10.1 North America
  • 10.1.1 North America Contraceptives Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 North America Contraceptives Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Contraceptives Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Contraceptives Market Breakdown, by Product
    • 10.1.1.1.2 US: North America Contraceptives Market Breakdown, by End User
    • 10.1.1.1.3 US: North America Contraceptives Market Breakdown, by Distribution Channel
  • 10.1.1.2 Canada: North America Contraceptives Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Contraceptives Market Breakdown, by Product
    • 10.1.1.2.2 Canada: North America Contraceptives Market Breakdown, by End User
    • 10.1.1.2.3 Canada: North America Contraceptives Market Breakdown, by Distribution Channel
  • 10.1.1.3 Mexico : North America Contraceptives Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Contraceptives Market Breakdown, by Product
    • 10.1.1.3.2 Mexico : North America Contraceptives Market Breakdown, by End User
    • 10.1.1.3.3 Mexico : North America Contraceptives Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Contraceptives Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Bayer AG
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Church & Dwight, Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 CooperSurgical (Cooper Companies, Inc.)
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Mayer Laboratories, Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Medicines360
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Merck & Co., Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Prosan International B.V.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Contraceptives Market

  1. Bayer AG
  2. Church & Dwight, Inc.
  3. CooperSurgical (Cooper Companies, Inc.)
  4. Mayer Laboratories, Inc.
  5. Medicines360
  6. Merck & Co., Inc.
  7. Prosan International B.V.
north-america-contraceptives-market